Sentence Production Training in Aphasia

December 14, 2024 updated by: Ji Yeon Lee, Purdue University

Structural Priming as a Treatment Component in Aphasia

This project focuses on developing a novel treatment for sentence production and comprehension in aphasia, using implicit priming. First set of experiments will aim examine which learning conditions are most effective in creating maximal training gains. Then, in a later study, the investigators will develop and test the efficacy of a novel treatment study based on findings from the first set of the studies.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Over five years, the investigators will conduct a series of studies to develop a novel intervention strategy for improving sentence production and comprehension in persons with aphasia. Specifically, the investigators will use implicit learning of grammar as a novel facilitator for language recovery in aphasia. The planned studies seek to test the hypothesis that implicit learning alters the central language system in PWA, creating lasting and generalized improvements in both sentence production and comprehension. Aim 1 will determine the extent to which different learning conditions modulate immediate and long-term improvement in sentence production. The investigators integrate multiple theories of language learning and apply them to make predictions about the trajectory of priming-induced learning in PWA. In Aim 2, using a set of eyetracking and sentence comprehension tasks, it will be investigated whether the effects of priming in production generalize to off-line (accuracy) and on-line (eye fixations) sentence comprehension and determine which learning conditions result in greater cross-modality generalization. In Aim 3, the investigators will develop and establish Phase I efficacy data of an implicit priming treatment, incorporating the crucial learning conditions supporting maximal retention from Aims 1 and 2. The project will recruit both individuals with aphasia and without aphasia.

Study Type

Interventional

Enrollment (Estimated)

104

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Indiana
      • West Lafayette, Indiana, United States, 47907
        • Recruiting
        • Purdue University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Individuals with post-stroke aphasia
  • At least 6 months post-onset of eft hemisphere stroke
  • Native speaker of English
  • Normal or corrected to normal hearing and vision
  • High-school educated
  • Difficulty communicating in sentences, with some ability to use words independently

Exclusion Criteria:

  • Severe apraxia of speech
  • Other neurological conditions affecting communication (e.g., dementia)
  • Uncontrolled psychiatric/psychological conditions affecting thinking and communication
  • Active alcohol/substance abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Structural priming training
Participants will be enrolled in 3 sessions of structural priming training (for experiment 1-3) or up to 15 treatment sessions (for experiment 4). Each session will be about 2 hour long, consisting of a set of tasks, including repeating, making, and remembering various types of sentences. In experiment 1-3, each participant will receive two different experimental priming conditions that are being compared within each session. In experiment 4, participants will receive a structural priming treatment in a single-subject design.
Participants will be trained to read, make, and recall sentences during each session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Production of target sentences on action description pictures
Time Frame: From baseline up to 1-week post training or 2-month post treatment
Production accuracy (percent correct)
From baseline up to 1-week post training or 2-month post treatment
Comprehension of target sentences in a sentence-to-picture matching task
Time Frame: From baseline up to 1-week post training or 2-month post treatment
Comprehension accuracy (percent correct)
From baseline up to 1-week post training or 2-month post treatment
Real-time comprehension of target sentences in a sentence-to-picture matching task
Time Frame: From baseline up to 1-week post training or 2-month post treatment
Changes in eye fixations to the target picture
From baseline up to 1-week post training or 2-month post treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Connected speech production - story retell
Time Frame: From baseline up to 2-month post treatment
Increased production of complex utterances as measured by proportion of sentence-level utterances out of all utterances
From baseline up to 2-month post treatment
Connected speech production - picture description
Time Frame: From baseline up to 2-month post treatment
Increased production of complex utterances as measured by proportion of sentence-level utterances out of all utterances
From baseline up to 2-month post treatment
Production of untrained sentences
Time Frame: From baseline up to 2-month post treatment
Production accuracy (percent correct)
From baseline up to 2-month post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jiyeon Lee, PhD, Purdue University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

May 30, 2026

Study Registration Dates

First Submitted

May 16, 2022

First Submitted That Met QC Criteria

June 10, 2022

First Posted (Actual)

June 13, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 14, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We plan to share de-identified individual data with other researchers upon request. Other study materials (e.g., analytic code) will be made available via Open Science Forum. We will also make study-specific data and materials available for journal publications as supplemental materials, as relevant.

IPD Sharing Time Frame

Starting 6 months after publication

IPD Sharing Access Criteria

Researchers of OSF will access the study materials or data made available via OSF. Deidentified individual data can also be shared with other researchers upon requests and the PI will review each request. Other supporting materials such as study stimuli or protocols will be shared with other researchers upon request.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aphasia

  • Teachers College, Columbia University
    Recruiting
    Aphasia | Aphasia, Acquired | Aphasia, Broca | Aphasia Non Fluent | Aphasia, Anomic | Aphasia Following Cerebral Infarction | Aphasia, Mixed | Aphasia, Expressive | Aphasia, Conduction | Aphasia, Rehabilitation
    United States
  • University of South Carolina
    National Institute on Deafness and Other Communication Disorders (NIDCD)
    Completed
    Stroke | Aphasia | Stroke, Ischemic | Aphasia, Broca | Aphasia, Anomic | Aphasia, Global | Aphasia, Fluent | Aphasia, Mixed | Aphasia, Jargon | Aphasia, Expressive | Aphasia, Conduction
    United States
  • Maya Henry
    National Institutes of Health (NIH); National Institute on Aging (NIA)
    Recruiting
    Semantic Dementia | Logopenic Progressive Aphasia | Nonfluent Aphasia, Progressive | Logopenic Variant Primary Progressive Aphasia | Semantic Variant Primary Progressive Aphasia (svPPA) | Nonfluent Variant Primary Progressive Aphasia (nfvPPA) | Progressive Aphasia | Logopenic Progressive Aphasia... and other conditions
    United States
  • University of California, Berkeley
    University of California, San Francisco; National Institute on Deafness and... and other collaborators
    Recruiting
    Aphasia | Aphasia, Acquired | Aphasia Following Cerebral Infarction | Aphasia, Non-fluent | Aphasia, Fluent | Aphasia Following Nontraumatic Intracerebral Hemorrhage
    United States
  • Maya Henry
    National Institute on Aging (NIA)
    Recruiting
    Logopenic Variant Primary Progressive Aphasia | Progressive Aphasia | Logopenic Progressive Aphasia (LPA) | Primary Progressive Aphasia(PPA) | Logopenic Variant of Primary Progressive Aphasia (LPA) | Progressive Aphasia in Alzheimer's Disease
    United States
  • University of Texas at Austin
    University of California, San Francisco; National Institute on Deafness and...
    Active, not recruiting
    Primary Progressive Aphasia | Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Semantic Memory Disorder | Nonfluent Aphasia, Progressive | Aphasia, Progressive
    United States
  • University of Texas at Austin
    National Institute on Deafness and Other Communication Disorders (NIDCD)
    Enrolling by invitation
    Primary Progressive Aphasia | Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Semantic Memory Disorder | Nonfluent Aphasia, Progressive | Aphasia, Progressive
    United States
  • Institute for Bioengineering of Catalonia
    Hospital Universitari Joan XXIII de Tarragona.; Universitat Pompeu Fabra
    Completed
    Aphasia | Aphasia, Broca | Aphasia, Wernicke | Aphasia, Fluent | Aphasia, Nonfluent
    Spain
  • Flint Rehabilitation Devices, LLC
    University of Texas
    Completed
    Broca Aphasia
    United States
  • Mayo Clinic
    National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting
    Primary Progressive Aphasia | Apraxia of Speech | PPA | Non-fluent Aphasia | Primary Progressive Non-fluent Aphasia
    United States

Clinical Trials on Sentence training

Subscribe